IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 176 filers reported holding IVERIC BIO INC in Q4 2021. The put-call ratio across all filers is 0.12 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $16,090 | -96.0% | 409 | -97.5% | 0.00% | -95.7% |
| Q1 2023 | $397,577 | +12.9% | 16,341 | -0.6% | 0.05% | +9.3% |
| Q4 2022 | $352,045 | +21.8% | 16,443 | +1.9% | 0.04% | -12.2% |
| Q3 2022 | $289,000 | +86.5% | 16,134 | +0.3% | 0.05% | +88.5% |
| Q2 2022 | $155,000 | -42.4% | 16,090 | +0.7% | 0.03% | -38.1% |
| Q1 2022 | $269,000 | +0.7% | 15,975 | 0.0% | 0.04% | +2.4% |
| Q4 2021 | $267,000 | +1953.8% | 15,975 | +1896.9% | 0.04% | +1266.7% |
| Q3 2021 | $13,000 | +30.0% | 800 | -60.0% | 0.00% | 0.0% |
| Q2 2020 | $10,000 | -61.5% | 2,000 | -33.3% | 0.00% | -66.7% |
| Q4 2019 | $26,000 | – | 3,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
| Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
| Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
| MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
| Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
| ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
| Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
| Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
| Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
| Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |